How do you interpret Pulmonary Function Tests (PFTs) results in patients with suspected respiratory diseases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Interpret Pulmonary Function Tests

Interpret PFTs using a systematic, stepwise approach: first assess test quality, then compare results to reference values, identify ventilatory patterns using FEV1/VC ratio as the primary discriminator, confirm patterns with additional measurements, assess severity, and integrate clinical context. 1, 2

Step 1: Assess Test Quality First

Before interpreting any numerical values, review test quality and identify technical errors—relying solely on computer-generated interpretations without quality review is a common and critical mistake. 1 Document the nature and extent of unacceptable maneuvers, as tests that are less than optimal may still contain useful information but require acknowledgment of potential errors. 1

Step 2: Use the Core Parameters

Limit primary interpretation to VC (or FVC), FEV1, and FEV1/VC ratio to avoid false-positive results. 1 When examining 14 different spirometric measurements, the rate of finding at least one "abnormal" test increases to 24% even in healthy subjects, compared to only 10% when using just these three core parameters. 1

  • Use the largest available VC from any maneuver (inspiratory, slow expiratory, or forced expiratory), as FVC is often reduced more than IVC or SVC in airflow obstruction. 1
  • FEV6 may substitute for VC if appropriate lower limit of normal (LLN) for FEV1/FEV6 is used. 1

Step 3: Identify the Ventilatory Pattern

Obstructive Pattern

An obstructive defect is defined by FEV1/VC ratio below the 5th percentile of predicted value (or <0.70). 1, 2

  • Look for a concave shape on the flow-volume curve, which reflects slowing of expiratory flow and is the hallmark of airflow obstruction. 1, 2
  • FEV1 is proportionally more reduced than VC in obstructive patterns. 1, 2
  • Additional supportive findings include proportionally greater reduction in FEF75% or FEF25-75% compared to FEV1, though these are not specific for small airway disease in individual patients. 1

Restrictive Pattern

A normal or increased FEV1/VC ratio (>85-90%) with reduced VC suggests restriction, but TLC <5th percentile is required to confirm true restriction. 2

  • Only 50% of cases with low VC actually have low TLC, so reduced VC alone does not prove restriction. 2
  • A convex pattern on the flow-volume curve is characteristic of restrictive patterns. 2

Mixed or Indeterminate Patterns

  • A normal FEV1/VC ratio with low values for both FEV1 and VC may indicate poor effort or a mixed obstructive-restrictive pattern. 2
  • When FEV1/VC is borderline, late expiratory flow measurements (FEF25-75%) may help suggest airway obstruction. 1

Step 4: Assess Severity

Use FEV1 % predicted to categorize severity into mild, moderate, and severe categories, though recognize that FEV1 correlates poorly with symptoms in individual patients. 1, 2 The severity classification is based on studies relating pulmonary function to work ability, daily function, morbidity, and prognosis. 1

Step 5: Evaluate Diffusing Capacity (DLCO)

Low DLCO indicates parenchymal disease, emphysema, or vascular involvement and is an important predictor of mortality. 2

  • Adjust DLCO interpretation for hemoglobin value and altitude. 2
  • In obstructive patterns, TLC measurement helps differentiate emphysema (increased TLC indicating hyperinflation) from asthma. 2

Step 6: Check Bronchodilator Response

A significant bronchodilator response is defined as an increase in FEV1 or FVC of >12% AND >200 mL. 2

  • The absence of a response does not rule out clinical benefit from bronchodilator therapy. 2
  • This is relevant primarily for obstructive patterns.

Step 7: Integrate Clinical Context

Record respiratory symptoms (cough, phlegm, wheezing, dyspnea), smoking status, and recent bronchodilator use to make interpretation clinically meaningful. 1, 2

  • Consider chest radiograph findings, hemoglobin value, and suspicion of neuromuscular disease or upper airway obstruction. 1, 2
  • Ask ordering physicians to state the clinical question and ask patients why they were sent for testing. 1

Common Pitfalls to Avoid

  • Do not examine multiple flow parameters simultaneously (beyond the core three), as this dramatically increases false-positive rates. 1
  • Do not use FVC alone in obstructive disease—it underestimates true VC compared to IVC or SVC. 1
  • Do not diagnose restriction without measuring TLC, as half of patients with low VC have normal TLC. 2
  • Do not rely on MVV routinely for diagnosis, as it correlates well with FEV1, though it may help identify neuromuscular disorders (disproportionate decrease relative to FEV1) or upper airway obstruction. 1
  • Consider upper airway obstruction when FEV1/PEF ratio >8 or when there is a flattened inspiratory flow loop with normal expiratory findings. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pulmonary Function Test Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Approach to Variable Extrathoracic Upper Airway Obstruction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.